Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asklepios BioPharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011821
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio also offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company collaborates with corporate, foundation, and academic organizations. It caters to pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Licensing Agreements 12
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Acquisition 18
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc – Key Competitors 19
Asklepios BioPharmaceutical Inc – Key Employees 20
Asklepios BioPharmaceutical Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc, Key Competitors 19
Asklepios BioPharmaceutical Inc, Key Employees 20

★海外企業調査レポート[Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ShaMaran Petroleum Corp. (SNM):企業概要、財務及び戦略的SWOT分析
    Summary ShaMaran Petroleum Corp. (ShaMaran) is an oil and gas company. The company explores and produces oil and gas assets. Its Atrush block is located north of Shaikan oil discovery. ShaMaran has drilled Atrush-1, Atrush-2, AT-3 and AT-4 wells in Atrush block. The company uses DQE31 drilling rig. …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Artesian Resources Corporation (ARTNA):企業概要、財務及び戦略的SWOT分析
    Summary Artesian Resources Corporation (Artesian) is a holding company. The company through eight subsidiaries offers water, wastewater and related services to residential, commercial, and government customers. Its services include residential services, commercial water and wastewater services, gove …
  • Samuel Heath and Sons Plc:企業の戦略・SWOT・財務分析
    SummarySamuel Heath and Sons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Universal Bioenergy, Inc. (UBRG):企業概要、財務及び戦略的SWOT分析
    Summary Universal Bioenergy, Inc. (Universal Bioenergy) is a diversified energy company. The company offers production, marketing and sale of natural gas, propane, coal, petroleum, liquefied natural gas, refined petroleum products and electricity. It also offers acquisition of oil and gas fields, le …
  • BioView Ltd. (BIOV):企業のM&A・提携動向(医療機器分野)
    Summary BioView Ltd. (BioView) is a medical device company that develops, manufactures and markets laboratory equipment for cancer screening and monitoring. The company offers products like Duet-3, Allegro Plus, Accord, Legato, Solo, SoloWeb, and biological preparation kits. It provides kits that in …
  • Groupe Pizzorno Environnement S.A. (GPE):企業概要、財務及び戦略的SWOT分析
    Summary Groupe Pizzorno Environnement S.A. (Pizzorno) is a waste management company. The company provides solution for household and industrial waste. It offers cleaning services such as waste collection, transport, sorting and recovery of household and industrial waste, street cleaning, decontamina …
  • H. Lundbeck A/S:企業の戦略・SWOT・財務情報
    H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report Summary H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vifor Pharma, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vifor Pharma, Ltd. Mergers and …
  • Zone Resources Inc. (ZNR)(石油・ガス分野):企業M&A動向
    Summary Zone Resources Inc. (Zone) is a mineral exploration company. The company identifies, acquires and explores oil and natural gas resources. It has lithium property interests in the Val D’or region of Quebec and iron ore interests in the northern Labrador Trough. Zone also provides services in …
  • Amerisur Resources Plc (AMER):企業のM&A・提携動向(石油・ガス分野)
    Summary Amerisur Resources plc (Amerisur) is an independent full-cycle oil and gas company. It focuses on the exploration, development and production of oil and natural gas in onshore South America, primarily in Colombia and Paraguay. Amerisur has working interests in the Put-12, Put-30 ,CPO-5 and T …
  • Tarsus Group Plc:企業のM&A・提携・投資分析
    Tarsus Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tarsus Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Dune Energy, Inc. (DUNR)(石油・ガス分野):企業M&A動向
    Summary Dune Energy, Inc. (Dune) is an independent oil and gas company. The company exploits, purchases, develops crude oil and natural gas properties. Its oil and natural gas properties consists of oil and natural gas wells and its interests in leasehold acreage, undeveloped and developed. Dune has …
  • Royal Dutch Shell plc (RDSA):企業のM&A・提携動向(発電分野)
    Summary Royal Dutch Shell plc (Shell) is an oil and gas company that explores for and produces oil and gas both from conventional fields and from sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream products. The c …
  • AXA SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AXA SA Mergers and Acquisitions …
  • Skyworks Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Skyworks Solutions, Inc. Merger …
  • Equifax, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Equifax, Inc. Mergers and Acqui …
  • aap Implantate AG (AAQ):企業のM&A・提携動向(医療機器分野)
    Summary aap Implantate AG (aap) is a medical device company that develops, manufactures and markets orthopedic products, biomaterials and trauma products. The company’s biomaterials include bone cements and accessories, bone substitutes, and collagen fleeces. It offers services such as product devel …
  • RAK Petroleum Plc (RAKP):企業の財務・戦略的SWOT分析
    Summary RAK Petroleum Plc (RAK Petroleum), a subsidiary of RAK Investment Auhtority, is oil and gas company that transports and trades oil, gas and petrochemicals. The company carries out upstream, midstream and downstream activities. It operates its projects in the Middle East and Africa. RAK Petro …
  • Sumitomo Corp (8053):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆